Poulami Chaudhuri

Poulami Chaudhuri is the Co-founder and CEO of Helex, a genomic medicine company developing lipid nanoparticle-delivered in vivo therapies for genetic kidney diseases and beyond. Their lead program targets autosomal dominant polycystic kidney disease (ADPKD), the largest genetic kidney disease in the world, affecting 12 million people globally. Helex is on a mission to build curative, disease-modifying medicines that are accessible to patients, including in India where rare diseases are not so rare. 

Poulami is a scientist and entrepreneur building at the intersection of genomic science, cutting-edge delivery technology and patient access. Her guiding principle is that the future of medicine must reach every patient, not just a privileged few. Spanning Boston and India, Helex was built with her co-founders on a vision to create deep genomic science from India for the world. Poulami won the Cartier Women's Initiative Science & Technology Pioneer Award in 2023, recognized for her work driving impact through innovation in healthcare.